Continuous Regional Analysis Device for Neonate Lung (CRADL)

March 19, 2019 updated by: Inez Frerichs, University Hospital Schleswig-Holstein
The purpose of the study is to assess whether Electrical Impedance Tomography (EIT) has the potential to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, recruitment manoeuvres, etc.) and for early recognition of complications like pneumothorax and endotracheal tube misplacement. The study design is purely observational.

Study Overview

Detailed Description

EIT data will be recorded during 72 hours of routine clinical treatment. To prevent any decisions based on EIT information, the clinicians will be blinded to the EIT findings during the study period. Data on clinical interventions and clinical findings will be recorded using a specially adapted graphical user interface on the EIT device in combination with a paper-based case report form (CRF). EIT data analysis will be performed off-line.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nicosia, Cyprus
        • Archbishop Makarios III Hospital
      • Oulu, Finland
        • Oulu University Hospital
      • Amsterdam, Netherlands
        • VU University Medical Center
      • Amsterdam, Netherlands
        • Academic Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 7 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This study specifically focuses on the EIT monitoring of preterm and term neonates, small infants and children up to the age of 7 years treated in NICU and PICU as this is the population where the need for regional lung function monitoring tools is most urgently needed to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, alveolar recruitment, etc.) and prevent/minimize the occurrence of acute (pneumothorax, endotracheal tube misplacement) and chronic (chronic lung disease or bronchopulmonary dysplasia) adverse effects.

Description

Inclusion Criteria:

  • Written, informed consent of both parents or legal representative
  • Admission in the NICU or PICU
  • Patients with or at high risk of developing respiratory failure needing respiratory support.

    o i.e. (oxygen need (FiO2>25%) AND noninvasive or invasive respiratory support) AND/OR repeated apnea with desaturations

  • Age from birth to 7 years o Initial focus will be on neonates up to 6 kg and 12 months age. Infants of higher weight up to 7 years age will be included as EIT belts for this age group become available.

Exclusion Criteria:

  • Post menstrual age less than 25 weeks
  • Body weight < 600 g
  • Electrically active implants
  • Thorax skin lesions
  • Prior participation for the same diagnosis of lung disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in aggregate measure of ventilation homogeneity (coefficient of variation and global inhomogeneity index of regional tidal volume) by > 10% compared with baseline
Time Frame: 72 hours
72 hours
Change in right-to-left and/or anteroposterior ventilation distribution by >10% compared with baseline
Time Frame: 72 hours
72 hours
Time and duration of right-to-left or left-to-right ventilation ratio >2:1
Time Frame: 72 hours
72 hours
Percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of < 700 Ohm
Time Frame: 72 hours
Skin contact impedance will be monitored continuously by the EIT device. If more than 6 sensors exhibit skin contact impedance > 700 Ohm, the examination is no longer suitable for analyzing. To assess the percentage of EIT measurements suitable for analyzing, we will calculate the percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of less than 700 Ohm.
72 hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Relationship between time of onset/end of non-invasive respiratory support and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time of intubation/extubation and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time of suctioning and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time and type of posture change and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time of surfactant administration and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time of clinically indicated radiological examination and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time of recruitment manoeuvre and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time of confirmed pneumothorax and EIT findings
Time Frame: 72 hours
72 hours
Relationship between time of confirmed endotracheal tube malposition and EIT findings
Time Frame: 72 hours
72 hours
Relationship between primary cause of respiratory failure and EIT findings
Time Frame: 72 hours
72 hours
Relationship between fraction of inspired oxygen over time and EIT findings
Time Frame: 72 hours
72 hours
Relationship between saturation of peripheral oxygen over time and EIT findings
Time Frame: 72 hours
72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2016

Primary Completion (Actual)

March 3, 2019

Study Completion (Actual)

March 3, 2019

Study Registration Dates

First Submitted

November 3, 2016

First Submitted That Met QC Criteria

November 8, 2016

First Posted (Estimate)

November 11, 2016

Study Record Updates

Last Update Posted (Actual)

March 21, 2019

Last Update Submitted That Met QC Criteria

March 19, 2019

Last Verified

March 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

3
Subscribe